Prescribing in Asthma and COPD – 2026 Update
- Description
- Curriculum
Course Format: Pre-recorded webinar
Duration: 1 hour
Recorded: September 2026
Lecturer: Ameet Gordhan – Specialist Respiratory Pharmacist
Delivery: Online, self-paced learning
Course Overview
Asthma and COPD are common respiratory conditions encountered in primary care. Keeping up to date with changing prescribing recommendations is essential to ensuring safe, effective and individualised treatment. This Asthma and COPD Prescribing Update 2026 focuses on the practical application of UK respiratory guidance, including recommendations from NICE and BTS/NICE/SIGN. The session explores prescribing decisions in asthma and COPD, the role of combination inhalers, appropriate use of inhaled corticosteroids and strategies for optimising treatment. Participants will develop their understanding of respiratory medicines and how to apply evidence-based recommendations to everyday clinical practice.
What Does the Course Cover?
Asthma Prescribing Update 2026
- Current UK asthma prescribing recommendations.
- The role of inhaled corticosteroids (ICS) in asthma management.
- Anti-inflammatory reliever (AIR) therapy.
- Maintenance and reliever therapy (MART).
- Identifying poor asthma control and excessive SABA use.
- Treatment escalation and review.
COPD Prescribing Update 2026
- Current approaches to pharmacological management of COPD.
- Short-acting and long-acting bronchodilators.
- LABA, LAMA and combination inhaled therapies.
- Appropriate use of inhaled corticosteroids.
- Optimising treatment for persistent breathlessness and exacerbations.
- Prescribing safety and medicines optimisation.
Inhaler Prescribing and Patient Safety
- Selecting appropriate inhaler devices.
- The importance of inhaler technique and adherence.
- Recognising inappropriate or ineffective prescribing.
- Individualising respiratory treatment.
- Supporting shared decision-making.
Who Should Attend?
This course is suitable for healthcare professionals involved in respiratory assessment, prescribing and medicines reviews, including:
- General Practitioners (GPs)
- Advanced Nurse Practitioners (ANPs)
- Advanced Clinical Practitioners (ACPs)
- Independent Nurse Prescribers
- Clinical Pharmacists and Independent Prescribing Pharmacists
- Practice Nurses
- Paramedic Practitioners
- Community Healthcare Professionals
It is particularly relevant to clinicians working in general practice, primary care, urgent care and community respiratory services.
Flexible Online Learning
This course was recorded in September 2026 and is available as an on-demand learning session through the Belmatt Learning Management System (LMS).
Learn at your own pace and revisit key prescribing principles to support your professional development.
Why Choose Belmatt Healthcare Training?
- Expert-led clinical education.
- Practical learning relevant to UK primary care.
- Focus on safe and effective prescribing.
- Flexible online access.
- Suitable for continuing professional development and reflective learning.
Frequently Asked Questions
Is this a live webinar? No. This is a recorded session originally delivered in September 2026 and available for online learning.
How long is the course?The recorded teaching session lasts approximately one hour.
Is the course suitable for independent prescribers? Yes. It is particularly relevant to nurse and pharmacist independent prescribers, GPs and advanced clinical practitioners involved in asthma and COPD management.
Does the course cover current UK guidance? The recording discusses UK respiratory prescribing recommendations relevant at the time of recording in September 2026. Learners should also consult the latest NICE guidance, local formularies and prescribing policies.
Can I complete the course at my own pace? Yes. The recording is available through the Belmatt LMS for flexible, self-directed learning.
-
1COPD and Asthma HandoutsText lesson
This section provides handouts for the session and some updated guidelines when prescribing in COPD and Asthma. This session was recorded in September 2026. Please consult local policies for any updates.
-
2COPD and AsthmaVideo lesson
This clinical update provides healthcare professionals with an evidence-based overview of the assessment, diagnosis and management of asthma and Chronic Obstructive Pulmonary Disease (COPD) in primary care.
The session explores current UK guidance, including NICE, BTS and SIGN recommendations, with a focus on accurate diagnosis, optimising inhaled therapies, recognising poor disease control and preventing exacerbations. Practical clinical considerations, prescribing updates and case-based discussions support safe and effective respiratory care
-
3Prescribing in Asthma and COPD – 2026 Update3 questions
Social Network